EXL — Elixinol Wellness Cashflow Statement
0.000.00%
Last trade - 00:00- AU$2.90m
- AU$5.22m
- AU$15.51m
Annual cashflow statement for Elixinol Wellness, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.405 | 0.386 | 1.56 | 0.103 | 0.03 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14.1 | -8.15 | -2.76 | -3.47 | -3.21 |
| Capital Expenditures | -0.292 | -0.012 | -0.017 | -0.06 | -0.101 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.464 | -0.857 | -1.03 | -0.006 | -0.115 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.172 | -0.869 | -1.04 | -0.066 | -0.216 |
| Financing Cash Flow Items | -0.11 | 0 | -0.199 | -0.564 | -0.339 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.16 | -0.757 | 1.61 | 3.92 | 3.65 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.1 | -9.79 | -2.16 | 0.37 | 0.327 |